Cargando…
Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
BACKGROUND: DNA originating from degenerate tumour cells can be detected in the circulation in many tumour types, where it can be used as a marker of disease burden as well as to monitor treatment response. Although circulating tumour DNA (ctDNA) measurement has prognostic/predictive value in metast...
Autores principales: | Lau, Edmund, McCoy, Patrick, Reeves, Fairleigh, Chow, Ken, Clarkson, Michael, Kwan, Edmond M., Packwood, Kate, Northen, Helen, He, Miao, Kingsbury, Zoya, Mangiola, Stefano, Kerger, Michael, Furrer, Marc A., Crowe, Helen, Costello, Anthony J., McBride, David J., Ross, Mark T., Pope, Bernard, Hovens, Christopher M., Corcoran, Niall M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430029/ https://www.ncbi.nlm.nih.gov/pubmed/32807235 http://dx.doi.org/10.1186/s13073-020-00770-1 |
Ejemplares similares
-
Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat
por: Mangiola, Stefano, et al.
Publicado: (2019) -
Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation
por: McCoy, Patrick J., et al.
Publicado: (2018) -
Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021) -
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
por: Stuchbery, Ryan, et al.
Publicado: (2016) -
Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
por: Cmero, Marek, et al.
Publicado: (2021)